ABBV vs MDT
By Alex · Tickerpine
AbbVie Inc. vs Medtronic plc, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | ABBV | MDT |
|---|---|---|
| Price | $265.79 | $91.14 |
| Market cap | $469.68B | $116.66B |
| P/E ratio | 74.7 | 24.4 |
| ROE | — | 9.84% |
| Profit margin | 9.80% | 13.20% |
| Revenue growth | 10.20% | 9.90% |
| Dividend yield | 2.62% | 3.10% |
| Beta | 0.28 | 0.57 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
ABBV vs MDT in plain English
- ABBV is the bigger company — about 4.0× the market cap of MDT.
- MDT is cheaper on earnings (P/E 24.4 vs 74.7).
- ABBV is growing revenue faster (10% vs 10%).
- MDT has the higher dividend yield (3.10% vs 2.62%).
How would $1,000 have done in each?
ABBV return calculator
See what $1,000 in AbbVie Inc. would be worth today.
MDT return calculator
See what $1,000 in Medtronic plc would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.